Equity Market Research
Wednesday, 3 June 2015
Glenmark Pharma: 4Q results marred by one-offs; FY16 outlook robust says Motilal Oswal Financial Services Ltd http://goo.gl/8vCheq
Glenmark Pharma: 4Q results marred by one-offs; FY16 outlook robust says Motilal Oswal Financial Services Ltd http://goo.gl/8vCheq
http://goo.gl/8vCheq
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment